Deleted Tweets From Scott Gottlieb, R-D.C.

RT @WHO: "2018 is a year of opportunity for WHO. It’s the year that will determine what WHO looks like in the future."—… https://t.co/aM7c8GWzut

Adult smoking rate fell to 14.4% for first half of 2017, continuing declines in adult cigarette smoking. More people are quitting. Those who smoke are smoking less. But we must do much more. #FDA comprehensive plan can advance, propel these gains https://

Be assured, during #shutdown, thousands of dedicated #FDA employees were still on the job ensuring security of food and medical product supply; protecting public safety. We’re grateful for all of our employees’ for their dedication; proud of our mission h

@theNASEM #FDA’s plan proposes lowering nicotine in combustible cigarettes to minimally/non-addictive levels; encouraging development of new products that may be less harmful than combusting tobacco. E-cigs could be one such alternative, but need proper r

We appreciate @theNASEM’s review of the complex public health considerations re: e-cigarettes. Their comprehensive report adds to our knowledge base and raises some important questions about the net effect of e-cigarettes: https://t.co/6pR4N80ocn

@theNASEM A lot of findings to date reflect the experience with e-cigs in a market where cigarettes were fully addictive and e-cigs unregulated. We’re proposing a much different future; with more kid protections and efforts to drive down combustible tobac

Report from @theNASEM helps identify further research needed to better understand net public health impact of e-cigarettes as we advance our policies to protect kids and significantly reduce the tobacco-related disease/death from combustible cigarettes: h

I’m looking forward to testifying next Tuesday before the @housecommerce Committee on #FDA’s continued implementation of #DQSA, the important role of pharmacy compounding, and the FDA’s congressional mandate to oversee the safety and quality of the manufa QT @HouseCommerce: NEXT WEEK: #SubHealth to conduct check up on safeguards for compounded medications >> https://t.co/Hq9f7p9IuV)

RT @FDATobacco: In the U.S., nearly 8 out of 10 deaths from chronic obstructive pulmonary disease (#COPD) are a result of smoking. https://t.co/x1o1e58Ruc

Protecting future generations from tobacco-related disease/death will always be our #1 priority. As FDA moves forward w/ our comprehensive plan on nicotine; we’re committed to efforts/policies that will best protect kids from all nicotine-containing produ

We’ve also expanded our public education efforts to include messaging re: dangers of youth use of e-cigarettes. A full-scale campaign launch is planned for later this year: https://t.co/QNXIsWHh4C. This is just one piece of FDA’s work to restrict youth ac

Today – 5 guidance documents issued with the latest steps FDA is taking to help food #importers & producers understand & effectively implement key safety provisions in #FSMA regulations https://t.co/QuAFlny5ei

RT @NatureBiotech: Read our Q&A with @US_FDA commissioner @SGottliebFDA about the previous year and his outlook for the future… https://t.co/GOt1vvSpJy

No child should be using any nicotine-containing product. #FDA vigorously enforces youth access restrictions and age verification requirements for e-cigarettes and other tobacco products, as well as prohibitions on free samples. We’ve taken thousands of e

RT @NCIDirector: Check out my latest blog post on the challenging landscape of cancer and aging https://t.co/awkuBoqj4c

#FDA intends to seek public comment on the role flavors in tobacco products play in attracting youth. We also plan to explore addtl restrictions on the sale/promotion of e-cigarettes (incl. restrictions on how products may be sold/advertised) to further ↓

RT @NIHDirector: Scott Gottlieb #FDA making a strong case for reducing global tobacco use at “Together for a Healthier World” sessio… https://t.co/vGXbePejMa

#FDA will continue to take action against unscrupulous vendors capitalizing on opioid epidemic, and preying on patients, by selling bogus products with baseless claims. We appreciate the work of our public and private partners in this effort and thank @FT

RT @califf001: Excellent. In God we trust. All others must show evidence that benefits exceed risks. Especially when promoting to despera… QT @SGottliebFDA: #FDA and FTC issue joint warning letters to the marketers and distributors of 12 opioid cessation products, for ill… https://t.co/0UABEZp8tU)

Curious about #biosimilars? Check out FDA’s new educational materials at https://t.co/JaC5aKAx8u.

RT @WHO: "2018 is a year of opportunity for WHO. It’s the year that will determine what WHO looks like in the future."—… https://t.co/aM7c8GWzut

Adult smoking rate fell to 14.4% for first half of 2017, continuing declines in adult cigarette smoking. More people are quitting. Those who smoke are smoking less. But we must do much more. #FDA comprehensive plan can advance, propel these gains https://

Be assured, during #shutdown, thousands of dedicated #FDA employees were still on the job ensuring security of food and medical product supply; protecting public safety. We’re grateful for all of our employees’ for their dedication; proud of our mission h

@theNASEM #FDA’s plan proposes lowering nicotine in combustible cigarettes to minimally/non-addictive levels; encouraging development of new products that may be less harmful than combusting tobacco. E-cigs could be one such alternative, but need proper r

We appreciate @theNASEM’s review of the complex public health considerations re: e-cigarettes. Their comprehensive report adds to our knowledge base and raises some important questions about the net effect of e-cigarettes: https://t.co/6pR4N80ocn

@theNASEM A lot of findings to date reflect the experience with e-cigs in a market where cigarettes were fully addictive and e-cigs unregulated. We’re proposing a much different future; with more kid protections and efforts to drive down combustible tobac

Report from @theNASEM helps identify further research needed to better understand net public health impact of e-cigarettes as we advance our policies to protect kids and significantly reduce the tobacco-related disease/death from combustible cigarettes: h

I’m looking forward to testifying next Tuesday before the @housecommerce Committee on #FDA’s continued implementation of #DQSA, the important role of pharmacy compounding, and the FDA’s congressional mandate to oversee the safety and quality of the manufa QT @HouseCommerce: NEXT WEEK: #SubHealth to conduct check up on safeguards for compounded medications >> https://t.co/Hq9f7p9IuV)

RT @FDATobacco: In the U.S., nearly 8 out of 10 deaths from chronic obstructive pulmonary disease (#COPD) are a result of smoking. https://t.co/x1o1e58Ruc

Protecting future generations from tobacco-related disease/death will always be our #1 priority. As FDA moves forward w/ our comprehensive plan on nicotine; we’re committed to efforts/policies that will best protect kids from all nicotine-containing produ

We’ve also expanded our public education efforts to include messaging re: dangers of youth use of e-cigarettes. A full-scale campaign launch is planned for later this year: https://t.co/QNXIsWHh4C. This is just one piece of FDA’s work to restrict youth ac

Today – 5 guidance documents issued with the latest steps FDA is taking to help food #importers & producers understand & effectively implement key safety provisions in #FSMA regulations https://t.co/QuAFlny5ei

RT @NatureBiotech: Read our Q&A with @US_FDA commissioner @SGottliebFDA about the previous year and his outlook for the future… https://t.co/GOt1vvSpJy

No child should be using any nicotine-containing product. #FDA vigorously enforces youth access restrictions and age verification requirements for e-cigarettes and other tobacco products, as well as prohibitions on free samples. We’ve taken thousands of e

RT @NCIDirector: Check out my latest blog post on the challenging landscape of cancer and aging https://t.co/awkuBoqj4c

#FDA intends to seek public comment on the role flavors in tobacco products play in attracting youth. We also plan to explore addtl restrictions on the sale/promotion of e-cigarettes (incl. restrictions on how products may be sold/advertised) to further ↓

RT @NIHDirector: Scott Gottlieb #FDA making a strong case for reducing global tobacco use at “Together for a Healthier World” sessio… https://t.co/vGXbePejMa

#FDA will continue to take action against unscrupulous vendors capitalizing on opioid epidemic, and preying on patients, by selling bogus products with baseless claims. We appreciate the work of our public and private partners in this effort and thank @FT

RT @califf001: Excellent. In God we trust. All others must show evidence that benefits exceed risks. Especially when promoting to despera… QT @SGottliebFDA: #FDA and FTC issue joint warning letters to the marketers and distributors of 12 opioid cessation products, for ill… https://t.co/0UABEZp8tU)

Curious about #biosimilars? Check out FDA’s new educational materials at https://t.co/JaC5aKAx8u.